3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
121
Lymphoid
71
Myeloid
25
Plasma cell
11
Dermatologic
5
Classical hematology
5
CNS
5
Sarcoma
4
Gastrointestinal
4
Breast
3
Other neoplasm
2
Other
2
Head & Neck
2
Gynecologic
2
Genitourinary
2
Thoracic
1
Other solid neoplasm
1
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
69
Gastro-enteropancreatic neuroendocrine tumor
8
Pheochromocytoma
7
Carcinoma, Neuroendocrine
7
Carcinoid Tumor
7
Adenoma, Islet Cell
7
Paraganglioma
6
Neoplasms
5
Melanoma
5
Breast Neoplasms
5
Thyroid Neoplasms
4
Sarcoma
4
Pancreatic Neoplasms
4
Neuroblastoma
4
Neoplasm Metastasis
4
Carcinoma
4
Serotonin Syndrome
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Neuroectodermal Tumors, Primitive
3
Mesothelioma
3
Meningioma
3
Liver Neoplasms
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Central Nervous System Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Merkel Cell
3
Carcinoma, Hepatocellular
3
Anus Neoplasms
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia
×
NET
×
90 days
×
Clear all
NCT02012699
2026-05-05
iCaRe2
University of Nebraska
Recruiting
999,999 enrolled